N

ENDRA Life Sciences
D

NDRA

5.31000
USD
-0.43
(-7.49%)
Market Closed
Volume
0
EPS
0
Div Yield
0
P/E
-0
Market Cap
96,322,322
OverviewSignalsIdeasNews
Related Instruments
    A
    AYTU
    -0.05000
    (-1.89%)
    2.60000 USD
    I
    INO
    -0.670
    (-6.28%)
    10.000 USD
    N
    NDRA
    0.002600
    (3.30%)
    0.081500 USD
    P
    PSTV
    0.00000
    (0.00%)
    1.80000 USD
    T
    TRIB
    -0.18000
    (-6.04%)
    2.80000 USD
    T
    TTOO
    0.16000
    (3.31%)
    4.99000 USD
    More
News

Title: ENDRA Life Sciences Inc

Sector: Healthcare
Industry: Diagnostics & Research
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH),chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.